U.S. federal trademark · Serial No. 75576866
cancer therapy, namely, the use of mono clonal antibodies and radioisotopes in humans to combine the therapeutic effects of the mono clonal antibody and radioisotopes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.